Delivery Order SPE2DB24D2205-SPE2DB25FEHPG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml pack quantities, with a ceiling value of $2,210. The contract, awarded on September 8, 2025, represents a firm fixed-price delivery order with a completion deadline of September 9, 2025. This award utilizes no set-aside designation and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a $2,750.65 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Provocholine Inhalation Solution in 18 mL packs. This is a firm fixed-price contract with a completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,538.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Provocholine inhalation solution in 18-milliliter packs. The contract is set to be completed by September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18mL pack configuration, valued at $1,100.26 under a firm fixed-price contract type. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-competitive delivery order represents a purchase of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution Pack (18ML) with a ceiling value of $2,526.72 under a firm fixed price contract type. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Provocholine 100 mg vials, valued at $27,352.78. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The ultimate completion date is set for September 3, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHPGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine Inhalation Solution in an 18ML pack format. This $25.1K firm fixed-price contract, issued on September 15, 2025, with a completion date of September 16, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1B global pharmaceutical supply vehicle valued through December 2026 that enables the company to provide comprehensive pharmaceutical and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering diverse pharmaceutical products and medical supplies across multiple therapeutic domains. Provocholine, a bronchial challenge agent used in pulmonary function testing, represents a specialized pharmaceutical commodity consistent with AmerisourceBergen's role as a comprehensive medical supply provider to the Department of Defense medical supply chain. The company's demonstrated capability to fulfill federal procurement requirements through open competition across a wide range of product categories and contract values underscores its position as a strategic supplier for military healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 9/15/25 |